Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/49814Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | PUSPARUM, Murih | - |
| dc.contributor.author | den Elzen, Wendy P. J. | - |
| dc.contributor.author | THAS, Olivier | - |
| dc.contributor.author | Ertaylan, Gokhan | - |
| dc.date.accessioned | 2026-08-18T07:33:17Z | - |
| dc.date.available | 2026-08-18T07:33:17Z | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-08-18T07:28:43Z | - |
| dc.identifier.citation | Scientific Reports, 16 (1) (Art N° 23387) | - |
| dc.identifier.uri | http://hdl.handle.net/1942/49814 | - |
| dc.description.abstract | Reference intervals (RIs) are the universal established methodology for interpreting numerical clinical data by comparing individual test results to population-based benchmarks. The quality of these RIs significantly influences individual-level decision-making. This study aims to answer the question on how we can effectively leverage an individual's personal data in conjunction with that of their peers to compute individual reference intervals (IRIs) for key clinical parameters relevant to disease detection and progression. We describe the IRIS workflow that includes prior data processing and data quality check procedures. The computation of IRI involves the test results of multiple "healthy" data points from the same subject(s) and also from the peers. The model adjusts for covariates like sex and age, enhancing accuracy. The workflow demonstrated the potential utility of IRI in clinical and omics data from two longitudinal studies. For healthy populations, IRIs showed diagnostic value in chronic diseases, while in diseased cohorts, they enabled effective disease monitoring. An integrated application IRIS has been developed, incorporating all described steps in an easy-to-use tool in research and/or clinical practice. The IRI may assist in (1) early detection of disease transition in chronic diseases and (2) monitoring personal disease progression. It facilitates the detection of small deviations in clinical measurements, either using standard clinical biochemistry test results or omics data. With adequate data infrastructure, the IRIS workflow can be integrated into clinical practice by embedding personalised biomarker baselines into AI-enabled decision support systems Such integration provides a complementary layer that enhances the sensitivity and specificity of clinical alerts and risk stratification. Ultimately, this approach has the potential to transform personalised disease diagnosis, management, and patient outcomes. | - |
| dc.description.sponsorship | Funding M.P. is funded through VITO and the Research Foundation—Flanders (FWO), as a postdoctoral fellow in fundamental research (grant number: 12AMD24N). This study received partial funding from the FWO Beyond the Genome project (grant number: G070722N). Acknowledgements We would like to thank all participants of the VITO IAM Frontier Study and IBS. We would also like to acknowledge the contribution of researchers and laboratory staff at VITO NV for operationalising the IAM Frontier cohort. | - |
| dc.language.iso | en | - |
| dc.publisher | NATURE PORTFOLIO | - |
| dc.rights | The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. | - |
| dc.subject.other | Reference interval | - |
| dc.subject.other | Reference interval | - |
| dc.subject.other | Chronic disease | - |
| dc.subject.other | Chronic disease | - |
| dc.subject.other | Proteomics | - |
| dc.subject.other | Proteomics | - |
| dc.subject.other | Metabolomics | - |
| dc.subject.other | Metabolomics | - |
| dc.subject.other | Clinical tests | - |
| dc.subject.other | Clinical tests | - |
| dc.subject.other | Precision medicine | - |
| dc.subject.other | Precision medicine | - |
| dc.title | Reference intervals reimagined with IRIS for earlier detection and better disease monitoring | - |
| dc.type | Journal Contribution | - |
| dc.identifier.issue | 1 | - |
| dc.identifier.volume | 16 | - |
| local.format.pages | 13 | - |
| local.bibliographicCitation.jcat | A1 | - |
| dc.description.notes | Pusparum, M (corresponding author), Flemish Inst Technol Res VITO, Environm Intelligence, Ind ZoneVlasmeer 5, B-2400 Mol, Belgium.; Pusparum, M (corresponding author), Hasselt Univ, Data Sci Inst, I Biostat, B-3500 Hasselt, Belgium. | - |
| dc.description.notes | murih.pusparum@vito.be | - |
| local.publisher.place | HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Article | - |
| local.bibliographicCitation.artnr | 23387 | - |
| dc.identifier.doi | 10.1038/s41598-026-52500-z | - |
| dc.identifier.pmid | 42173996 | - |
| dc.identifier.isi | 001834090600013 | - |
| local.provider.type | wosris | - |
| local.description.affiliation | [Pusparum, Murih; Ertaylan, Gokhan] Flemish Inst Technol Res VITO, Environm Intelligence, Ind ZoneVlasmeer 5, B-2400 Mol, Belgium; [Pusparum, Murih; Thas, Olivier] Hasselt Univ, Data Sci Inst, I Biostat, B-3500 Hasselt, Belgium; [den Elzen, Wendy P. J.] Univ Amsterdam, Dept Lab Med, Lab Specialized Diagnost & Res, Amsterdam UMC, NL-1105 AZ Amsterdam, Netherlands; [den Elzen, Wendy P. J.] Amsterdam Publ Hlth Res Inst, NL-1105 AZ Amsterdam, Netherlands; [den Elzen, Wendy P. J.] Amsterdam Gastroenterol Endocrinol Metab, NL-1105 AZ Amsterdam, Netherlands; [Thas, Olivier] Univ Ghent, Dept Math Comp Sci & Stat, B-9000 Ghent, Belgium; [Thas, Olivier] Univ Wollongong, Natl Inst Appl Stat Res Australia, Wollongong, NSW 2500, Australia | - |
| local.uhasselt.international | yes | - |
| item.contributor | PUSPARUM, Murih | - |
| item.contributor | den Elzen, Wendy P. J. | - |
| item.contributor | THAS, Olivier | - |
| item.contributor | Ertaylan, Gokhan | - |
| item.accessRights | Open Access | - |
| item.fulltext | With Fulltext | - |
| item.fullcitation | PUSPARUM, Murih; den Elzen, Wendy P. J.; THAS, Olivier & Ertaylan, Gokhan (2026) Reference intervals reimagined with IRIS for earlier detection and better disease monitoring. In: Scientific Reports, 16 (1) (Art N° 23387). | - |
| crisitem.journal.issn | 2045-2322 | - |
| crisitem.journal.eissn | 2045-2322 | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s41598-026-52500-z.pdf | Published version | 2.98 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.